1418293-58-9

(R)-N-Isopropyl-N-methyl-1,2-propanediamine Di-trifluoroacetic Acid is an intermediate in the synthesis of potential compounds used for the treatment of neurodegeneration, muscle atrophy or metabolic syndromes via the inhibition of Histone Deacetylase 4 (HDAC4), a protein that play a critical role in the transcriptional regulation and developmental events.